Medtec Morning Brief - August 7: Policy Updates, Strategic Collaborations, and Product Approvals
Medtronic
Medical Device Manufacturer
Policy Dynamics: Medical Insurance Supports the Full-chain Development of Innovative Drugs and Devices
China's National Healthcare Security Administration Holds Five Consecutive Seminars, Focusing on Full Lifecycle Support for Innovative Medical Devices and Drugs, Sending Important Signals:
Core Theme: Covering comprehensive value evaluation of innovative drugs and medical devices in medical insurance, price policy empowering innovation, medical insurance data services for R&D, current status and direction of R&D, patient capital support, etc.
Full-chain Support: From R&D project initiation (supported by real-world data), clinical application (promoting the implementation of tubeless technology, brain-computer interfaces, etc.), to value assessment and medical insurance access (studying the pricing mechanism for newly launched drugs, dynamic catalog adjustment), and then to capital support, a full-cycle guarantee is constructed.
Participating Entities: Research institutions in colleges and universities (such as Peking University, Changping National Laboratory), enterprises (BeiGene, Hengrui Medicine, United Imaging Healthcare, etc.), medical institutions (West China Hospital, etc.), investment institutions (National Social Security Fund, China Investment Corporation, etc.) and media, forming a diverse synergy.
Investment, Financing and Mergers & Acquisitions
Alcon AcquisitionStaar Surgical: Acquired for $1.5 billion ($28 per share in cash)，Aimed at enhancing the capability of surgical vision correction solutions, covering all stages of myopia treatment; Staar's sales declined due to weakness in the Chinese market, making this acquisition its optimal choice.
Ypsomed Sells Business: Swiss medical technology company Ypsomed sells its diabetes care business to TecMed AG for 420 million Swiss francs.Focus on subcutaneous self-injection solutions; the deal includes the mylife Loop insulin pump system and related assets, employee transfers, and TecMed plans to integrate tubular pump and patch pump technologies.
Orchestra BioMed Financing: Secures $111 Million in Funding(Including investments from Medtronic, Ligand, etc.), for the global pivotal trial of BackBeat Therapy (a bioelectronic pacemaker-like blood pressure reduction technology); Medtronic has committed an additional $20 million, expanding the collaboration to develop a leadless pacemaker that supports AVIM.
ST Kelly Asset Change: Plans to sell 36.9% equity stake in Jienuo Medical for 1.62 billion yuan, and exit its investment in Jingzheng Medical through a targeted dividend (1.62 billion yuan) and capital reduction (81.1 million yuan). After the transaction, it will no longer hold shares in the two companies.
Product Progress and Approval
GI Windows Product Approved: Otoloc Magnetic Compression Anastomosis System, developed by GI Windows in which Johnson & Johnson and GE Healthcare have invested, received FDA 510(k) clearance. It is the first technology to achieve immediate lumen anastomosis in enterotomy through self-forming magnets, revolutionizing traditional sutures and staplers.
United Imaging Healthcare Photon CountingCT Enters Clinical UseSelf-developed photon-counting spectral CT initiates clinical testing at Zhongshan Hospital and Ruijin Hospital, breaking through the limitations of traditional CT imaging, reducing radiation dose by 60%-90%, and filling the gap in China-produced technology (globally, only two foreign companies have achieved commercialization).
Medtronic Chief Communications Officer Adjustment:Torod Neptune Resigns as Global Chief Communications Officer and Chairman of the Medtronic Foundation (Effective August 15), Succeeded by Amy Jo Meyer, Vice President of Corporate Communications;Team structure adjustment: Global communications, corporate marketing, and other departments are now under the leadership of the Chief Human Resources Officer.
Sony Medical Collaborates with Siemens Healthineers: Establish global strategic partnerships, Siemens Healthineers angiography systemsARTIS integrates with Sony's NUCLeUS audiovisual management platform to enable seamless control of audiovisual data and remote collaboration during interventional procedures, enhancing clinical efficiency and educational value.
Product Recall
PhilipsBiPAP Machine Recall: Due to alarm issues (which may cause treatment interruption or machine shutdown), A30, A40, and V30 models of BiPAP ventilators were recalled last year. So far, 13 injuries and 8 deaths have been reported. The company updated its guidance, recommending patients who cannot tolerate treatment interruptions to switch to alternative devices. Previous recalls were due to soundproofing foam issues, and the company is cooperating with the FDA consent decree for corrective actions.
Want to be the first to grasp the latest news and in-depth insights of the medical device industry? Add the official customer service WeChat of "Medical Device Innovation Network" to join the exclusive reader group. You can not only get real-time industry updates but also communicate with peers, and share your questions, opinions, and expectations, allowing thoughts to collide and resonate within the circle.
Previous Recommendations
Medical Device Companies Race for IPO: Who Will Follow in the Footsteps of NorthX Bio?
